Celularity Inc. Class A Common Stock

CELUNASDAQ • USD
0.61 USD
↘ 0.02 (3.51%)🟢LIVE (AS OF 01:58 PM EST)
🟢Market: OPEN

CELU is currently priced at $0.61. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, exceptional Return on Equity (130.3%) and a bearish Death Cross on the long-term moving averages. On the valuation side, CELU appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Nov 13, 2026.

Open?$0.63
High?$0.76
Low?$0.60
Prev. Close?$0.63
Volume?75.1K
Avg. Volume?153.6K
VWAP?$0.61
Rel. Volume?0.49x
Bid / Ask
Bid?$0.52 × 100
Ask?$0.70 × 100
Spread?$0.18
Midpoint?$0.61
Valuation & Ratios
Market Cap?20.4M
Shares Out?32.5M
Float?6.6M
Float %?20.3%
P/E Ratio?N/A
P/B Ratio?-0.58
EPS?-$1.43
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.
Employees
115
Market Cap
20.4M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2021-07-19
Address
170 PARK AVE
FLORHAM PARK, NJ 07932
Phone: (908) 768-2170
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
40
Z-Score?
0
Momentum?
48
Short Sent.?
36
Piotroski F-Score?4/9Mixed
Altman Z-Score?-16.48Distress
Confidence?59%Low
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?8.12%Elevated
Short Interest?534.8K
Days to Cover?2.3
Free Float6.6M
Avg Daily Volume229.9K
Settlement Date2026-10-30
Financial Health
Current Ratio?0.11Weak
Quick Ratio?0.10Weak
Cash Ratio?0.01Low
Debt/Equity?-1.06Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
92/100
P/E?
N/A▾
P/B?
S&P
97
-0.58CHEAP▾
P/S?
Peers
100
S&P
85
1.10CHEAP▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-1.4CHEAP▾
EV/Sales?
Peers
100
S&P
60
3.08FAIR▾
Returns & Efficiency
ROE?
Peers
50
S&P
97
130.3%STRONG▾
ROA?
S&P
3
-48.2%WEAK▾
Cash Flow & Enterprise
FCF?$-8923000
Enterprise Value?$57.5M
Fundamentals ratios updated end of day